Junqi Niu Selected Research

Bile Acids and Salts (Bile Acids)

1/2022	Efficacy and safety of alfosbuvir plus daclatasvir in Chinese patients with hepatitis C virus genotypes 1, 2, 3, and 6 infection: An open-label, phase 2 study.
1/2021	Metabolomic Analysis Reveals the Therapeutic Effects of MBT1805, a Novel Pan-Peroxisome Proliferator-Activated Receptor Agonist, on α-Naphthylisothiocyanate-Induced Cholestasis in Mice.
8/2019	Serum metabolome and targeted bile acid profiling reveals potential novel biomarkers for drug-induced liver injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Junqi Niu Research Topics

Disease

64	Infections 04/2024 - 01/2010
42	Chronic Hepatitis B 04/2024 - 01/2007
32	Fibrosis (Cirrhosis) 10/2023 - 11/2012
21	Chronic Hepatitis C 04/2024 - 01/2012
17	Hepatocellular Carcinoma (Hepatoma) 10/2023 - 02/2014
15	Liver Diseases (Liver Disease) 11/2022 - 02/2008
13	Hepatitis B 03/2020 - 09/2011
12	Liver Cirrhosis (Hepatic Cirrhosis) 08/2023 - 01/2014
11	Virus Diseases (Viral Diseases) 04/2024 - 01/2013
9	Inflammation (Inflammations) 09/2022 - 11/2012
9	Neoplasms (Cancer) 01/2022 - 11/2012
6	Non-alcoholic Fatty Liver Disease 10/2023 - 12/2017
4	Hepatitis C 10/2023 - 01/2018
4	Hepatitis 09/2022 - 01/2014
4	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2022 - 05/2012
3	Chronic Hepatitis (Chronic Active Hepatitis) 04/2024 - 09/2016
3	COVID-19 12/2023 - 01/2022
3	Coinfection 10/2023 - 03/2014
3	Liver Neoplasms (Liver Cancer) 10/2023 - 11/2019
3	Communicable Diseases (Infectious Diseases) 10/2023 - 12/2021
3	Anemia 03/2021 - 05/2019
3	Disease Progression 01/2020 - 01/2019
2	Drug-Related Side Effects and Adverse Reactions 10/2023 - 01/2016
2	Obesity 10/2022 - 01/2021
2	End Stage Liver Disease 01/2022 - 01/2020
2	Wounds and Injuries (Trauma) 10/2021 - 05/2021
2	Ascites 10/2021 - 11/2020
2	Hepatolenticular Degeneration (Wilson's Disease) 01/2021 - 01/2016
2	Persistent Infection 01/2020 - 11/2019
2	Insulin Resistance 01/2020 - 06/2019
2	Chemical and Drug Induced Liver Injury 08/2019 - 05/2019
2	Viremia 01/2018 - 02/2009
2	Type 2 Diabetes Mellitus (MODY) 01/2017 - 12/2015
1	Bone Resorption 02/2024

Drug/Important Bio-Agent (IBA)

35	Antiviral Agents (Antivirals)IBA 10/2023 - 02/2008
18	InterferonsIBA 09/2023 - 01/2014
17	Hepatitis B e AntigensIBA 01/2023 - 01/2007
14	Proteins (Proteins, Gene)FDA Link 08/2023 - 01/2012
13	Ribavirin (Virazole)FDA LinkGeneric 10/2023 - 01/2012
13	Biomarkers (Surrogate Marker)IBA 08/2023 - 11/2012
11	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2011
10	RNA (Ribonucleic Acid)IBA 08/2023 - 09/2014
10	Hepatitis B Surface Antigens (HBsAg)FDA Link 09/2022 - 01/2012
9	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 03/2014
8	Alanine Transaminase (SGPT)IBA 09/2022 - 03/2014
7	Transaminases (Aminotransferases)IBA 01/2022 - 12/2017
6	CytokinesIBA 03/2021 - 01/2011
6	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 12/2011
6	Telbivudine FDA Link 01/2020 - 02/2008
5	AlbuminsIBA 10/2023 - 01/2018
5	Tenofovir (Viread)FDA Link 06/2023 - 01/2012
5	BilirubinIBA 01/2022 - 01/2018
5	Lamivudine (Epivir)FDA Link 04/2015 - 01/2007
4	VaccinesIBA 12/2023 - 01/2019
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2023 - 01/2015
4	AntigensIBA 01/2023 - 01/2018
4	entecavir FDA Link 09/2022 - 06/2017
4	Therapeutic UsesIBA 01/2022 - 01/2011
4	SofosbuvirIBA 09/2021 - 01/2018
3	daclatasvirIBA 11/2023 - 11/2016
3	Immunoglobulin G (IgG)IBA 10/2023 - 11/2019
3	Hemoglobins (Hemoglobin)IBA 10/2023 - 08/2016
3	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 08/2019
3	LipidsIBA 01/2021 - 12/2011
3	ApolipoproteinsIBA 09/2019 - 11/2016
3	Interleukin-10 (Interleukin 10)IBA 11/2018 - 05/2016
3	InterleukinsIBA 11/2018 - 09/2011
3	adefovir dipivoxil (Hepsera)FDA Link 02/2012 - 01/2010
2	EnzymesIBA 04/2024 - 08/2018
2	Transcription Factors (Transcription Factor)IBA 04/2024 - 01/2017
2	Protease Inhibitors (Protease Inhibitor)IBA 10/2023 - 09/2014
2	Interferon Type IIBA 01/2023 - 03/2018
2	MicroRNAs (MicroRNA)IBA 11/2022 - 12/2017
2	pradefovirIBA 10/2022 - 01/2020
2	Alkaline PhosphataseIBA 01/2022 - 01/2021
2	HDL CholesterolIBA 01/2022 - 01/2018
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022 - 01/2021
2	CollagenIBA 10/2021 - 05/2021
2	Toll-Like Receptors (Toll-Like Receptor)IBA 03/2021 - 11/2019
2	Ethanol (Ethyl Alcohol)IBA 02/2020 - 01/2019
2	Insulin (Novolin)FDA Link 01/2020 - 06/2019
2	NucleotidesIBA 11/2019 - 01/2016
2	Indicators and Reagents (Reagents)IBA 04/2019 - 01/2014
2	AntibodiesIBA 01/2019 - 05/2012
2	Glycoproteins (Glycoprotein)IBA 01/2019 - 01/2014
2	pgRNAIBA 01/2019 - 01/2017
2	Lipoproteins (Lipoprotein)IBA 01/2019 - 11/2016
2	hydroxide ionIBA 02/2018 - 01/2012
2	Interferon-alpha (Interferon Alfa)IBA 11/2016 - 04/2016
2	Interleukin-33IBA 06/2012 - 01/2012
1	ImmunosorbentsIBA 04/2024
1	OsteoprotegerinIBA 02/2024
1	RANK LigandIBA 02/2024
1	Hematoxylin (Haematoxylon)IBA 02/2024
1	NF-kappa B (NF-kB)IBA 02/2024
1	Polyethylene (Polythene)IBA 02/2024
1	Eosine Yellowish-(YS) (Eosin)IBA 02/2024
1	Melitten (Melittin)IBA 02/2024

Therapy/Procedure

29	Therapeutics 01/2023 - 02/2008
4	Liver Transplantation 01/2020 - 07/2013